Table 15.

Key performance indicators of ischaemic stroke from Chinese Stroke Center Alliance in 2018

Key performance indicators	Relative frequency	% (95% CI)
Acute performance measures
Intravenous rtPA≤4.5 hours	16 270/67 122	24.2 (23.9% to 24.6%)
Early antithrombotics	223 740/264 348	84.6 (84.5% to 84.8%)
DVT prophylaxis	35 321/83 605	42.3 (41.9% to 42.6%)
Discharge performance measures
Antithrombotics	229 080/261 594	87.6 (87.4% to 87.7%)
Anticoagulants for AF	8448/19 283	43.8 (43.1% to 44.5%)
BP lowering for HTN	130 477/202 912	64.3 (64.1% to 64.5%)
Glucose-lowering for hyperglycaemic	59 039/75 330	78.4 (78.1% to 78.7%)
Statin for LDL	238 145/266 767	89.3 (89.2% to 89.4%)
Additional quality measures
Smoking cessation	61 221/63 630	96.2 (96.1% to 96.4%)
Dysphagia screen	214 407/269 428	79.6 (79.4% to 79.7%)
Rehabilitation	202 787/269 428	75.3 (75.1% to 75.4%)
Summary performance measures
Composite score	0.77±0.21
All-or-none measure	73 017/269 428	27.1 (26.9% to 27.3%)

AF, atrial fibrillation; BP, blood pressure; DVT, deep vein thrombosis; HTN, hypertension; LDL, low-density lipoprotein; rtPA, recombinant tissue plasminogen activator.